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Abstract
Botulinum toxin (BTX) is used in different cosmetic and therapeutic procedures. In dentistry, BTX has been used successfully
for management of drooling. BTX injection into salivary glands has damaging adverse effects on all components of the gland.
Epidermal Growth Factor (EGF) is well known for its regenerative properties. The aim of this study was to investigate the
effect of BTX injections on the submandibular salivary glands of adult female Albino rats, when administered solely or in
conjunction with EGF through measuring the expression of cytokeratin in the parenchyma of the gland. Sixty rats were used
in this study and were equally divided into control (saline) group, BTX group and EGF + BTX group (Combined treatment).
The results obtained from this study showed that cytokeratin expression in submandibular salivary glands of rats significantly
decreased after a single subcutaneous injection of 2.5 units of BTX in 0.1ml saline. However, daily intraperitoneal injections
of EGF with a dose of 10 µg/Kg body weight restored normal levels of cytokeratin expression, as well as normal integrity
of the submandibular salivary glands. Further studies are necessary to confirm the finding from the current study through immunohistochemical localization of E-cadherin as well as scanning electron microscopy examination of submandibular salivary
glands treated with BTX and EGF.
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Introduction
Botulinum toxin (BTX) is produced by a Gram-positive rodshaped anaerobic bacterium, Clostridium botulinum and few
similar Clostridia (C. butyricum, C. baratii and C. argentinense)
[1]. BTX is a protein complex consisting of a neurotoxic part
that targets synaptic proteins involved in vesicular neurotransmitter release. There are seven well known antigenically distinct BTX
serotypes (A–G), with the most recent serotype H being reported
and currently characterized [2, 3]. Additionally, these serotypes
also have further subtypes [4, 5].
The cosmetic use of BTX was first reported in 1992 as a safe
and simple procedure that is more effective than soft tissue augmentation and then in 2000 the FDA approved botulinum type A
(BTXA) and botulinum type B (BTXB) as treatments for cervical
dystonia and glabellar (frown) lines [6]. Since the introduction of

BTX into the health field, it has become a versatile drug in various
fields of medicine. The clinical applications of BTX continue to
expand and additional novel applications are becoming popular
[7].
The pharmacological inhibition of salivary glands by intra-glandular injection of BTX leads to blocking of acetylcholine release
at the neuro-glandular junction and produces a distinct reduction
in salivary flow [8]. All neurotoxin types suppress secretion of
acetylcholine at nerve endings. However, type A is the most researched, and studies about the effects of other serotypes are well
on track [9].
BTX injection into the salivary glands is a safe and effective method of drooling treatment. Success rates as high as 89% to 95%
were evident when injected in major salivary glands. As BTX is
injected locally, this averts the systemic side effects seen with anticholinergic medications [10].
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Numerous studies have been reported in the literature with regards to the benefits of BTX in the treatment of hypersalivation
due to different aetiological factors [11-13]. Literature evaluating
the histological and ultrastructural effects of BTX on the salivary
glands is scarce [11, 14, 15], and to date, no clinical trials associated with epidermal growth factor (EGF) injection in BTX treated salivary glands have been reported. Therefore, the aim of the
present investigation is to study the possible effects of the most
commonly used commercial brand of Botulinum toxin - Botox®
(Allergan Inc. Irvine, CA, USA) either separately or coupled with
Epidermal Growth Factor (Biovision Inc. Milpitas, CA, USA) on
the submandibular salivary glands of adult female Albino rats
through immunohistochemical localization of the cytokeratin in
the parenchyma of the gland.

Materials and Methods
This project was reviewed and granted ethical approval by the
Suez Canal University Research Ethics Committee (SUEZ-REC
35/2014).
Sixty healthy adult female Albino rats, three months old and 200220 gm body weight were used in this study. The rats were obtained
from Kasr El Aini animal experimental unit, Faculty of Medicine,
Cairo University. The rats were housed in separate cages, five rats
per cage and kept in an environment with controlled temperature
(25°C), humidity (45%-75%), and photoperiod (12:12 hour lightdark cycle). The animals were fed natural diet and supplied drinking water Ad Libitum throughout the whole experimental period.
The rats were acclimatized for one week before the initiation of
the experiment.
The animals were randomly divided into three groups as follows:
Control group: consisted of 20 rats, subjected to subcutaneous
injection of 0.1 ml saline in the region of the right and left submandibular salivary glands and served as controls.
Botox® (BTX) group: consisted of 20 rats that were subjected to
single dose of subcutaneous injection of 2.5 unit botulinum toxin
type A – Botox® (Allergan Inc. Irvine, CA, USA), reconstituted
in 0.1 ml of physiologic saline in the region of the right and left
submandibular salivary glands [8].
EGF group (Botox® + Epidermal growth factor): consisted of
20 rats, that were injected once subcutaneously with 2.5 unit botulinum toxin in 0.1 ml saline (Allergan Inc. Irvine, CA, USA) as in
BTX group and on the next day they were subjected to daily intra
peritoneal injection of Epidermal Growth Factor (Biovision Inc.
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Milpitas, CA, USA) in a dose of 10 µg/Kg body weight for sixty
days [16].
At the end of the experiment, all animals were sacrificed by euthanasia and thseir submandibular salivary glands were dissected
immediately after euthanasia.
Submandibular salivary glands were processed for histological
examination and stained with Immuno-peroxidase staining for
immunohistochemical localization of cytokeratin in the glandular
tissue using staining reaction incubated by Anticytokeratin - CK
number 5,6 and 18 Antibody (Thermo Fisher Scientific, Scoresby,
VIC, Australia).
For cytokeratin immunohistochemical localization, negative controls were prepared by substituting the primary antibody by a
nonspecific serum of the same dilution as its respective antibody
and the procedures were continued as usual. Six sections from
each submandibular salivary glands stained with anticytokeratin
antibody were selected, examined with ZEISS Primo Star light
microscopy and photographed by Tucsen IS 1000 10.0MP Camera in the Oral Biology Laboratory, Faculty of Dentistry, British
University in Egypt.
The staining reaction of the different immunohistochemical parameters of the different groups was scored as follows:
(-) negative staining reactivity.
(+) weak positive staining reactivity.
(++) moderate positive staining reactivity.
(+++) strong positive staining reactivity.
The intensity of the immunohistochemical staining results from
different groups were histomorphometrically analyzed using Image J computer system (1.46 a, NIH, USA). For each selected section, six microscopic fields were selected and captured at a magnification 200X using a digital video camera mounted on a light
microscope (CX21, Olympus, Japan). Images were then transferred to the computer system for analysis.
Images were manually corrected for brightness and contrast.
Color thresholding was then performed automatically after
which pictures were converted to RGB stack type. Masking of
the brown cytokeratin, immuno-stain was performed by red color
where any brown stain of any intensity was considered positive
whereas the background grey stain was considered negative (Fig.
1). Area fraction was then calculated automatically representing
the area percentage of immune positive cells to the total area of
the microscopic field.

Figure 1. Showing an example of the cytokeratin expression in the control group (a) and in the EGF group (b). Cytokeratin
expression was masked in red color using the Image J computer software.
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Statistics
All data obtained from histomorphometric analysis was statistically described in terms of range, mean, ± standard deviation
(±SD), and median. Comparison between groups was done using
Kruskal Wallis analysis of variance (ANOVA) test with ConoverInman test for independent samples as post hoc multiple 2-group
comparisons. A p value of <0.05 was considered statistically significant. All statistical analysis was done using the Statistical Package for the Social Sciences version 21 (SPSS Inc., Chicago, IL).

Results
Negative Control
Sections taken from the submandibular salivary glands of rats
from the control group and incubated with non-specific serum
and colour developed by DAB revealed negative staining reaction
of all elements forming the glands.
Control Group
Serous secretory cells showed a moderate to strong positive staining reaction of their cytoplasm while mucous secretory cells represented negative staining pattern. Strong positive reaction was
detected in most of the tissue sections around the secretory acini
(Fig. 2a).
All the duct system including the intercalated duct, granular convoluted tubules, the striated ducts as well as the excretory ducts
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revealed strong positive staining reaction. The pattern of staining represented as diffuse cytoplasmic staining in the striated and
excretory ducts while the granular convoluted tubules showed
staining at the granular parts. Moderate to strong positive staining reaction was found in the connective tissue surrounding the
excretory ducts as well as walls of the blood vessels (Figs. 2a, 2b).
Botox® group
Serous secretory acini revealed negative to weakly positive staining to anticytokeratin antibody. Intercalated, striated and excretory ducts as well as granular convoluted tubules showed weakly
positive staining reaction while connective tissue cells and walls
of blood vessels walls showed weakly positive staining reaction
(Figs. 2c, 2d).
EGF group (Botox® + Epidermal Growth Factor):
Serous secretory cells showed moderate to strong positive reaction of their cytoplasm and strong positive reaction were observed around the secretory acini in most of the tissue sections
(Figs. 2e, 2f).
Ductal cells of intercalated, striated and excretory ducts showed
strong positive reaction represented as diffuse cytoplasmic staining while granular convoluted tubules showed strong positive reaction at the granular parts. Moderate to strongly positive staining reaction was found in the connective tissue surrounding the
excretory ducts as well as the walls of the blood vessels (Fig 2f).
Table 1 summarizes the staining intensity of cytokeratin in differ-

Figure 2. A photomicrograph of the rat submandibular salivary gland. (a): Control group showing moderate to strong positive reaction in acini (black arrows) and strong positive reaction in ductal cells (red arrows) to cytokeratin 5,6 &18 (anticytokeratin original mag. x 100). (b): Control group showing strong positive reaction in excretory ductal cells (red arrows) to
cytokeratin 5,6 &18 (anticytokeratin original mag. x 200). (c): Botox (BTX) group showing weak reaction in acini and ductal
cells (black arrows) to cytokeratin 5,6 &18 (anticytokeratin original mag. x 100). (d): Botox (BTX) group showing weak positive reaction in acini (black arrows) and moderate positive reaction (red arrows) in excretory ductal cells to cytokeratin 5,6
&18 (anticytokeratin original mag. x 100). (e): Epidermal Growth Factor (EGF) group showing moderate to strong positive
reaction (black arrows) in acini to cytokeratin 5,6 &18 (anticytokeratin original mag. x 200). (f): Epidermal Growth Factor
(EGF) group showing moderate to strong positive reaction in acini (black arrows) and ductal cells (red arrows) to cytokeratin 5,6 &18 (anticytokeratin original mag. x 200).

Table 1. Illustrates the staining intensity scores of the submandibular salivary glands to Cytokeratin.
Group
Control Botox
EGF
Serous cells
++/+++
-/+
++/+++
Mucous cells
Myoepithelial cells
++
-/+
++
Intercalated ducts
+++
+
+++
Striated cells
+++
+
+++
Granular convoluted tubules
+++
+
+++
Excretory ducts
+++
+
+++
Connective tissue cells
++/+++
+
++/+++
Wall of blood vessels
++/+++
+
++/+++
- Negative staining reactivity. + Weak positive staining reactivity. ++ Moderate positive staining reactivity. +++ Strong positive staining reactivity.
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ent components of the submandibular salivary glands.
Statistical Results
Histomorphometric analysis: Histomorphometric analysis of
the three groups of the submandibular salivary gland revealed
that the highest mean area percent occupied by cytokeratin immunostaining was recorded in the control group, whereas the lowest
value was recorded in the Botox® (BTX) group.
Statistical analysis of variance (ANOVA test), revealed that the
difference in the mean area percent of expression of cytokeratin
immunostaining was extremely statistically significant (p<0.0001).
The mean values of the cytokeratin mean area percentage in all
groups of submandibular salivary gland were summarized in table
2.
Comparison between different groups
A pairwise comparison was held between cytokeratin mean area
expression percentage in control group and the other experimental groups using an unpaired (independent) Student’s t-test (Table
3).
There was a statistically significant decrease in the cytokeratin
expression area percentage in the BTX group than the control
group (p<0.0001). Furthermore, there was a statistically significant increase in the cytokertain expression area percentage
in EGF group when compared to the BTX group (p<0.0001).
Finally, there was a slight decrease in the cytokeratin expression
area percentage in the EGF group when compared to the control
group which was not statistically significant.

Discussion
Botulinum toxin (BTX), that is known to inhibit the release of
acetylcholine in different types of nerve endings, was used in this
study separately or in conjunction with epidermal growth fac-

tor (EGF) to detect their opposing effects on the submandibular salivary gland of female Albino rats. Botox® was chosen in
the present study as it is currently the most cosmetic injectable
product widely used in the world [16]. Furthermore, the clinical
applications of BTX extend beyond facial cosmetic therapy. BTX
injections are a safer treatment modality for other non-cosmetic
procedures when compared to pharmacotherapy or surgical intervention in terms of complications and mortality. These non-cosmetic applications include salivary secretory disorders, excessive
sweating, facial pain, and head and neck movement disorders [17].
In the present study, EGF was used to investigate its repair and
healing capacity in the submandibular salivary gland after BTX
injection as EGF has emerged as a powerful regulator of stem
cells and tissue regeneration [18, 19].
Keratins have an influence on the mitotic activity and the architecture (e.g. cell polarity and cell shape) of epithelial cells. They
are described to provide a scaffold (through self-bundling and
by forming thicker strands) for epithelial cells and tissues to resist mechanical stress, maintain structural integrity, mechanical
resilience and cell polarity, as well as protect against changes in
hydrostatic pressure [20, 21]. Furthermore, keratins and keratin
filaments are associated with other cellular functions such as cell
signalling, cell transport, cell compartmentalization and cell differentiation [22]. Keratin filaments also influence cell metabolic
processes by regulating protein synthesis and cell growth [23,
24]. Therefore, Cytokeratin was chosen in the present study as
an immunohistochemical marker to evaluate the extent of damage caused by botulinum toxin as well as evaluate the amount of
repair after administration of EGF.
In the present investigation, the submandibular salivary glands of
the Botox® (BTX) group, represented a weak positive reaction
to cytokeratins # 5,6 and 18, which was in contrast to a strong
reaction in the control group. Moreover, myoepithelial cells were
stained positively in the control group and showed weak positive
staining reactivity in the BTX group. The decrease in the cytokeratin expression in BTX group could be explained to be a result

Table 2. Illustrates the mean values and standard deviation (SD) of the area percentage of expression of Cytokeratin immunostaining in the submandibular salivary gland of the different groups.
Group
No. of cases
Max
Min
Mean
SD
Median

Control group
20
63.03
47.84
56.51
4.67
57.75

BTX group
20
26.21
18.96
21.01
1.98
20.66

EGF group
20
61.75
41.63
47.67
3.84
47.4

Table 3. Illustrates the results of the descriptive statistical pairwise comparison between cytokeratin area percentage in the
submandibular salivary gland of the control group and other groups.
Comparison
Control vs. Botox
Control vs. EGF
Botox vs. EGF

Mean difference L T value P value
35.537
27.215 < 0.0001*
8.844
9.232
0.922
26.665
13.455 < 0.0001*
* Statistically significant
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of the atrophic and degenerative changes caused by the BTXA to
different parenchymal elements within the submandibular salivary
glands which causes deformation in the acinar cells and defects
within the cellular junctions which ultimately results in reduction
in the secretory function of the acini. This is in agreement with
several studies which reported that changes from the normal architecture of the gland could potentially affect the glands adversely [24-26] and is associated with a decrease or negative reactivity
to cytokeratin [27-29]. Furthermore, it has been reported that Botox® has a number of adverse effects on submandibular salivary
glands including the reduction of Myosin expression and changes
to the ultrastructure picture [30, 31].
The repair potential and healing capacity of Epidermal Growth
Factor (EGF) has been reported in a number studies including
reversing the damage caused by a number of factors including
Diabetes Mellitus [32-35]. The findings from the current study
are in alignment with previous studies where EGF restored the
normal cytokeratin levels in acinar and ductal cells after a single
Botox® injection.
Cytokeratin # 5,6 and 18 expression in the EGF group was similar
to the control group. Serous acini and ductal cells showed strong
to moderate reaction reactivity. The stronger reaction revealed by
the duct cells is explained by the sequence of cytodifferentiation
of the ductal cells before the terminal branches, as the acinar cells
are the last to develop, which results in less cytokeratin formation. In addition to the above, myoepithelial cells were evident
in the surroundings of the acini and intercalated ducts and were
stained positively confirming its epithelial character. No statistically significant difference was found in the mean area percentage of cytokeratin expression between control and EGF groups.
These results are in alignment with a number studies that identified cytokeratin 5, 6 and 18 expression as a common finding in
cytoplasm of serous acini and ducts of normal salivary glands
[27, 28, 36, 37].

Conclusion
EGF plays an important role in tissue regeneration of the submandibular salivary glands following damage sustained as a result
of Botox® (BTX) injection. Daily intraperitoneal injection of epidermal growth factor in a dose of 10 µg/Kg body weight for two
months can reverse the damage caused by a single Botox® (BTX)
injection and restore the normal features of the submandibular
salivary gland. This was confirmed by immunohistochemical localization of cytokeratin expression.
Recommendations and future research
Further research is being conducted by our team to investigate
the effect of EGF on the submandibular salivary glands in albino
rats treated with Botox® through localization of E-cadherin. The
finding obtained from all immunohistochemical markers will be
confirmed using histological examination.
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